Related Experiment Video
Updated: Aug 13, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
Clinical results with the Acorn cardiac restraint device with and without mitral valve surgery
1Department of Surgery, Hospital of the University of Pennsylvania, Silverstein, PA 19104, USA. michael.acker@uphs.upenn.edu
Abstract:
Progressive left ventricular (LV) remodeling is part of the unfavorable natural history in patients with heart failure (HF). The CorCap Cardiac Support Device (CSD) is a mesh device that is implanted around the heart to reduce wall stress and the first therapy specifically designed to address LV remodeling. Early clinical studies have shown that the CSD is safe and associated with improvements in LV structure and function and patient symptoms. The CorCap was studied in the largest prospective randomized multicentered trial of a surgical device ever completed. The study demonstrated both safety and effectiveness of the CorCap in patients with advanced heart failure and remodeled ventricles.
Related Concept Videos
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse III: Nursing Management

